1. Australia Stocks

  2. •

    Health services

  3. •

    Medical/Nursing services
Healius Limited

Healius Limited

AASX:HLS
0.42
AUD
+0.03
(+6.41%)
-0.78EPS
570.01MMarket Cap
Feb 24Next Earn
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
Revenue per Share
2.69
2.82
2.77
2.84
2.98
2.75
2.36
2.84
3.71
2.77
2.65
1.85
- -
Basic EPS, GAAP
0.29
0.24
0.13
-0.89
0.02
0.09
-0.1
0.07
0.49
-0.6
-0.98
-0.21
- -
Free Cash Flow per Basic Share
0.24
-0.01
0.14
0.16
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
0.16
0.09
0.11
0.1
0.1
0.08
0.03
0.08
0.16
0.06
- -
0.41
- -
Book Value per Share
4.85
4.23
4.15
3.2
3.12
3.06
2.87
2.87
3.12
2.45
1.43
0.81
- -
Tangible Book Value per Share
-1.23
-1.17
-0.97
-1.05
-1.15
-0.75
-0.28
-0.42
-0.81
-0.75
-0.45
0.14
- -
Basic Weighted Avg Shares
565
573
583
584
584
656
673
669
630
616
660
726
726
Sales/Revenue/Turnover
1,520
1,614
1,614
1,659
1,740
1,805
1,585
1,901
2,336
1,707
1,746
1,344
- -
Operating Margin (%)
19.82
12.64
9.47
4.99
4.05
6.18
4.63
12.73
20.88
5.75
3.75
0.01
- -
Depreciation Expense
94
162
157
137
115
69
218
247
279
277
281
224
- -
Net Income, GAAP
163
136
75
-517
9
56
-70
44
308
-368
-646
-151
- -
Effective Tax Rate (%)
30.35
- -
32.27
- -
75.55
32.81
- -
60.49
29.48
- -
- -
- -
- -
Profit Margin (%)
10.69
8.46
4.64
-31.16
0.51
3.1
-4.45
2.3
13.18
-21.55
-36.98
-11.25
- -
Working Capital
-50
-114
-30
-65
-115
-45
-111
-385
-269
-285
-300
-194
- -
LT Debt
1,095
1,057
896
879
860
797
1,574
1,472
1,555
1,503
1,327
731
- -
Total Equity
2,748
2,447
2,428
1,869
1,824
2,055
1,931
1,857
1,922
1,506
1,041
588
- -
Return on Invested Capital (%)
5.48
- -
1.68
- -
0.58
2.7
- -
2.62
9.33
- -
- -
- -
- -
Return on Capital (%)
5.41
- -
3.27
- -
0.64
2.85
- -
1.79
8.78
- -
- -
- -
- -
Return on Common Equity (%)
5.99
5.26
3.07
-24.07
0.48
2.88
-3.54
2.31
16.3
-21.46
-50.71
-18.57
- -

Capital Structure

AUD

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

AUD

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

AUD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
- -
Free Cash Flow
- -
- -
- -
Net Income, GAAP
- -
- -
- -
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -

Semi-annual Revenue

AUD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
1,746
2025
- -
- -
1,344
2026
- -
- -
- -

Semi-annual Earnings Per Share

AUD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
-0.98
2025
- -
- -
-0.21
2026
- -
- -
- -

Semi-annual Dividends Per Share

AUD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
- -
2025
- -
- -
0.41
2026
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Paul Anderson
Full Time Employees
8,000
Sector
Health services
Industry
Medical/Nursing services
Address
161 Castlereagh Street Sydney NSW Australia 2000
IPO Date
Jul 3, 1998
Website
healius.com.au
Similar Companies
Hims & Hers Health, Inc. (NYSE:HIMS)
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA)
Mobile-health Network Solutions (NASDAQ:MNDR)
Dr. Lal PathLabs Limited (NSE:LALPATHLAB)
Tenon Medical, Inc. (NASDAQ:TNON)
Teladoc Health, Inc. (NYSE:TDOC)
Business
Healius Limited (ASX: HLS) operates as a leading Australian healthcare company focused on delivering pathology, diagnostic imaging, and day hospitals services. The company provides comprehensive pathology services through its Primary Healthcare Australia division, encompassing routine and specialist testing such as biochemistry, hematology, microbiology, and genetics; diagnostic imaging via I-MED Radiology Network, offering magnetic resonance imaging (MRI), computed tomography (CT), ultrasound, X-ray, nuclear medicine, and positron emission tomography (PET); and day hospitals under the Day Hospitals Australia network, specializing in surgical procedures including ophthalmology, orthopedics, cardiology, and gastroenterology. Healius serves public and private patients, general practitioners, specialists, and hospitals across metropolitan, regional, and rural areas in Australia, with operations concentrated in all states and territories. Founded in 2002 and headquartered in Sydney, New South Wales, the company has no major subsidiaries outside its core divisions following a strategic demerger of its primary care business in 2021. In the past two years, Healius has pursued operational efficiencies by divesting non-core assets, including the sale of its medical centers to not-for-profit operators in 2023, and launched expanded telehealth-integrated pathology reporting to enhance accessibility amid post-pandemic demand. Additionally, the company announced a A$100 million equity raise in late 2024 to fund digital transformation initiatives and capacity expansions in high-growth imaging modalities.

Company News

Company News APIChatGPT